| Product NDC: | 63323-140 |
| Proprietary Name: | Cladribine |
| Non Proprietary Name: | CLADRIBINE |
| Active Ingredient(s): | 1 mg/mL & nbsp; CLADRIBINE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-140 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076571 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20041201 |
| Package NDC: | 63323-140-10 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-140-10) > 10 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 63323-140-10 |
| Proprietary Name | Cladribine |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-140-10) > 10 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 63323-140 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CLADRIBINE |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20041201 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | CLADRIBINE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Purine Antimetabolite [EPC] |